<DOC>
	<DOCNO>NCT02079285</DOCNO>
	<brief_summary>&lt; Background/aims &gt; Rapid onsite evaluation ( ROSE ) endoscopic ultrasound-guided fine needle aspiration biopsy ( EUS-FNAB ) specimens attend cytopathologists demonstrate improve diagnostic yield EUS-FNAB . The practice ROSE , however , varies across EUS program Unites States , Europe area world . The investigator plan perform prospective evaluation yield EUS-FNAB absence ROSE , adequacy specimen assess single endosonographer . &lt; Methods &gt; All EUS-FNAB procedure perform experienced endosonographer adequacy specimen obtain EUS-FNAB also assess endosonographer . A specimen consider adequate adequate number representative cell lesion . Samples consider adequate interpreted malignancy , highly atypical suggestive malignancy , atypical favor reactive change , negative malignancy . Performance characteristic EUS-FNAB include sensitivity , specificity , accuracy determine compare EUS-FNAB result final diagnosis lesion , base upon surgical pathology clinical follow-up 6 month repeat imaging .</brief_summary>
	<brief_title>Prospective Evaluation Diagnostic Accuracy Endoscopic Ultrasound-guided Fine Needle Aspiration Biopsy ( EUS-FNAB ) Absence Rapid Onsite Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Any patient undergo EUSFNA diagnostic evaluation pancreas lesion Patients refuse undergo EUSFNA</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>